Danxia Yu1, Xiao-Ou Shu2, Eric F Howard3, Jirong Long2, Wayne J English4, Charles R Flynn4. 1. Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: danxia.yu@vumc.org. 2. Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. 3. Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. 4. Division of General Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
BACKGROUND: Evidence from longitudinal patient studies regarding gut microbial changes after bariatric surgery is limited. OBJECTIVE: To examine intraindividual changes in fecal microbiome and metabolites among patients undergoing Roux-en-Y gastric bypass or vertical sleeve gastrectomy. SETTING: Observational study. METHODS: Twenty patients were enrolled and provided stool samples before and 1 week, 1 month, and/or 3 months after surgery. Shallow shotgun metagenomics and untargeted fecal metabolomics were performed. Zero-inflated generalized additive models and linear mixed models were applied to identify fecal microbiome and metabolites changes, with adjustment for potential confounders and correction for multiple testing. RESULTS: We enrolled 16 women and 4 men, including 16 white and 4 black participants (median age = 45 years; presurgery body mass index = 47.7 kg/m2). Ten patients had Roux-en-Y gastric bypass, 10 had vertical sleeve gastrectomy, and 14 patients provided postsurgery stool samples. Of 47 samples, median sequencing depth was 6.3 million reads and 1073 metabolites were identified. Microbiome alpha-diversity increased after surgery, especially at 3 months. Significant genus-level changes included increases in Odoribacter, Streptococcus, Anaerotruncus, Alistipes, Klebsiella, and Bifidobacterium, while decreases in Bacteroides, Coprocosccus, Dorea, and Faecalibacterium. Large increases in Streptococcus, Akkermansia, and Prevotella were observed at 3 months. Beta-diversity and fecal metabolites were also changed, including reduced caffeine metabolites, indoles, and butyrate. CONCLUSIONS: Despite small sample size and missing repeated samples in some participants, our pilot study showed significant postsurgery changes in fecal microbiome and metabolites among bariatric surgery patients. Future large-scale, longitudinal studies are warranted to investigate gut microbial changes and their associations with metabolic outcomes after bariatric surgery.
BACKGROUND: Evidence from longitudinal patient studies regarding gut microbial changes after bariatric surgery is limited. OBJECTIVE: To examine intraindividual changes in fecal microbiome and metabolites among patients undergoing Roux-en-Y gastric bypass or vertical sleeve gastrectomy. SETTING: Observational study. METHODS: Twenty patients were enrolled and provided stool samples before and 1 week, 1 month, and/or 3 months after surgery. Shallow shotgun metagenomics and untargeted fecal metabolomics were performed. Zero-inflated generalized additive models and linear mixed models were applied to identify fecal microbiome and metabolites changes, with adjustment for potential confounders and correction for multiple testing. RESULTS: We enrolled 16 women and 4 men, including 16 white and 4 black participants (median age = 45 years; presurgery body mass index = 47.7 kg/m2). Ten patients had Roux-en-Y gastric bypass, 10 had vertical sleeve gastrectomy, and 14 patients provided postsurgery stool samples. Of 47 samples, median sequencing depth was 6.3 million reads and 1073 metabolites were identified. Microbiome alpha-diversity increased after surgery, especially at 3 months. Significant genus-level changes included increases in Odoribacter, Streptococcus, Anaerotruncus, Alistipes, Klebsiella, and Bifidobacterium, while decreases in Bacteroides, Coprocosccus, Dorea, and Faecalibacterium. Large increases in Streptococcus, Akkermansia, and Prevotella were observed at 3 months. Beta-diversity and fecal metabolites were also changed, including reduced caffeine metabolites, indoles, and butyrate. CONCLUSIONS: Despite small sample size and missing repeated samples in some participants, our pilot study showed significant postsurgery changes in fecal microbiome and metabolites among bariatric surgery patients. Future large-scale, longitudinal studies are warranted to investigate gut microbial changes and their associations with metabolic outcomes after bariatric surgery.
Authors: Sayeed Ikramuddin; Judith Korner; Wei-Jei Lee; John E Connett; William B Inabnet; Charles J Billington; Avis J Thomas; Daniel B Leslie; Keong Chong; Robert W Jeffery; Leaque Ahmed; Adrian Vella; Lee-Ming Chuang; Marc Bessler; Michael G Sarr; James M Swain; Patricia Laqua; Michael D Jensen; John P Bantle Journal: JAMA Date: 2013-06-05 Impact factor: 56.272
Authors: Antje Damms-Machado; Suparna Mitra; Asja E Schollenberger; Klaus Michael Kramer; Tobias Meile; Alfred Königsrainer; Daniel H Huson; Stephan C Bischoff Journal: Biomed Res Int Date: 2015-02-01 Impact factor: 3.411
Authors: M F Hjorth; H M Roager; T M Larsen; S K Poulsen; T R Licht; M I Bahl; Y Zohar; A Astrup Journal: Int J Obes (Lond) Date: 2018-02-06 Impact factor: 5.095
Authors: Zehra Esra Ilhan; John K DiBaise; Sydney E Dautel; Nancy G Isern; Young-Mo Kim; David W Hoyt; Athena A Schepmoes; Heather M Brewer; Karl K Weitz; Thomas O Metz; Michael D Crowell; Dae-Wook Kang; Bruce E Rittmann; Rosa Krajmalnik-Brown Journal: NPJ Biofilms Microbiomes Date: 2020-03-13 Impact factor: 7.290